The trademark application ANGIOSAFE was filed by AngioSafe, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 10, 2024, and still open for oppositions.
The application was filed in English (Italian was selected as the second language).
Goods And Services
The mark was filed in class 42 with following description of goods:
Clinical research in the field of coronary and peripheral arterial or venous diseases
Medical device research and development
Medical research in the field of coronary and peripheral arterial or venous diseases
Design, development and testing of new medical devices and accessories
Development of new technology for others in the field of medical devices
Development of new technology, namely, devices for coronary and peripheral vascular interventions.